Patents by Inventor Brigitte Le Mauff

Brigitte Le Mauff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180355316
    Abstract: The present invention relates to method of amplifying a population of antigen-specific memory CD4+ T cells using artificial presenting cells expressing HLA class II molecules. In particular, the present invention relates to a method of amplifying a population of antigen-specific memory CD4+ T cells comprising the steps of i) providing a population of artificial antigen presenting cells consisting host cells that are genetically modified to stably express at least one MHC class II molecule along with at least one accessory molecule ii) loading the population of artificial antigen presenting cells of step i) with an amount of at least one antigen of interest and iii) coculturing the suitable population of a T cells with the population of artificial antigen presenting cells of step ii).
    Type: Application
    Filed: December 2, 2016
    Publication date: December 13, 2018
    Inventors: Jean-Baptiste LATOUCHE, Brigitte LE MAUFF QUESTER, Olivier TOUTIRAIS
  • Patent number: 6214342
    Abstract: Mean survival times of a functional transplant of solid organs in a patient are increased by administering to the patient an initial dosing of a therapeutically effective amounts of a monoclonal antibody directed against the human LFA-1 molecule in the two hours after grafting and then administering daily dosing during a period of approximately nine days.
    Type: Grant
    Filed: October 30, 1995
    Date of Patent: April 10, 2001
    Assignee: Imtix-Sangstat
    Inventors: Gilles Alberici, Pierre Caudrelier, Brigitte Le Mauff, Maryvonne Hourmant, Jean-Paul Soulillou